LATTERELL VENTURE PARTNERS
Latterell Venture Partners is a venture capital firm specialized in startups and early stage healthcare companies, including biotechnology, pharmaceutical, research instrument, biomaterial, medical device, healthcare IT, and diagnostic ventures. The firm invests in early stage healthcare companies with innovative technologies, large market opportunities, and passionate entrepreneurs. It offers a collection of venture capital, entrepreneurial, technical, clinical, and collaborative skills enabling entrepreneurs to create successful startups. Founded in 2001, Latterell Venture Partners is based in San Francisco, California.
LATTERELL VENTURE PARTNERS
Industry:
Finance Financial Services Venture Capital
Founded:
2001-01-01
Status:
Active
Contact:
(925) 242-2618
Email Addresses:
[email protected]
Technology used in webpage:
DigiCert SSL Yahoo DNS Yahoo Hushmail
Similar Organizations
Venrock
Venrock is a venture capital firm investing in technology and healthcare companies.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-11-30 | Viracta Therapeutics | Latterell Venture Partners investment in Series E - Viracta Therapeutics | N/A |
| 2019-05-09 | Pulmonx | Latterell Venture Partners investment in Series G - Pulmonx | 65 M USD |
| 2017-04-04 | Viracta Therapeutics | Latterell Venture Partners investment in Series B - Viracta Therapeutics | 18.4 M USD |
| 2016-05-24 | Neuraltus Pharmaceuticals | Latterell Venture Partners investment in Venture Round - Neuraltus Pharmaceuticals | 14.94 M USD |
| 2016-05-10 | Aptinyx | Latterell Venture Partners investment in Series A - Aptinyx | 65 M USD |
| 2014-12-03 | Naurex | Latterell Venture Partners investment in Series C - Naurex | 80 M USD |
| 2014-04-02 | Transcend Medical | Latterell Venture Partners investment in Series C - Transcend Medical | 29 M USD |
| 2012-12-17 | Naurex | Latterell Venture Partners investment in Series B - Naurex | 38 M USD |
| 2012-04-01 | Neuraltus Pharmaceuticals | Latterell Venture Partners investment in Venture Round - Neuraltus Pharmaceuticals | 1.5 M USD |
| 2012-03-12 | Viracta Therapeutics | Latterell Venture Partners investment in Series B - Viracta Therapeutics | 13 M USD |